journal article·2023-11-14

Quantitatively Lighting up the Spatial Organization of CD47/SIRPα Immune Checkpoints on the Cellular Membrane with Single-Molecule Localization Microscopy

Yurong Wei, Min Zhao, Tianpei He, Na Chen, Li Rao, Long Chen, Yun Zhang, Yanbing Yang, Quan Yuan

ACS Nano· Volume 17· Issue 21
Publisher page

Abstract

Immunotherapy including immune checkpoint inhibition has reinvigorated the current cancer treatment field. The development of efficient cancer immunotherapies depends on a thorough understanding of the status of immune checkpoints and how they interact. However, the distribution and spatial organization changes of immune checkpoints during their interactions at the single-molecule level remain difficult to directly visualize due to the lack of in situ imaging techniques with appropriate spatial and stoichiometric resolution. Herein, we report the direct visualization and quantification of the spatial distribution and organization of CD47 on the bladder tumor cell membrane and SIRPα on the macrophage membrane by using a single-molecule localization imaging technique called quantitative direct stochastic optical reconstruction microscopy (QdSTORM). Results showed that a portion of CD47 and SIRPα was present on cell membranes as heterogeneous clusters of varying sizes and densities prior to activation. Quantitative analyses of the reconstructed super-resolution images and theoretical simulation revealed that CD47 and SIRPα were reorganized into larger clusters upon binding to each other. Furthermore, we found that blocking the immune checkpoint interaction with small-molecule inhibitors or antibodies significantly impacted the spatial clustering behavior of CD47 on bladder tumor cells, demonstrating the promise of our QdSTORM strategy in elucidating the molecular mechanisms underlying immunotherapy. This work offers a promising strategy to advance our understanding of immune checkpoint state and interactions while also contributing to the fields including signal regulation and cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Phagocytosis and Immune Regulation · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Institute of Molecular Medicine, Renmin Hospital of Wuhan University, School of Microelectronics, Wuhan University, Wuhan 430072, P. R. China

Hubei International Scientific and Technological Cooperation Base of Pesticide and Green Synthesis, Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, College of Chemistry, Central China Normal University, Wuhan 430079, P. R. China

Department of Computer and Information Science, Faculty of Science and Technology, University of Macau, Macau 999078, P. R. China

CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350025, P. R. China

Funding

State Key Laboratory of Chemo/Biosensing and Chemometrics · National Key Research and Development Program of China · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · New Cornerstone Science Foundation

References (48)

Show source-provided references
1. 10.1038/s41568-019-0186-910.1038/s41568-019-0186-9 ↗
2. 10.1038/nrc163010.1038/nrc1630 ↗
3. 10.1038/s41568-019-0116-x10.1038/s41568-019-0116-x ↗
4. 10.1126/science.aar406010.1126/science.aar4060 ↗
5. 10.1038/s41568-019-0183-z10.1038/s41568-019-0183-z ↗
6. 10.1038/s41586-019-1456-010.1038/s41586-019-1456-0 ↗
7. 10.1126/science.aax018210.1126/science.aax0182 ↗
8. 10.1002/cphc.20140276510.1002/cphc.201402765 ↗
9. 10.1038/s41577-019-0218-410.1038/s41577-019-0218-4 ↗
10. 10.1073/pnas.112162310910.1073/pnas.1121623109 ↗
11. 10.1016/j.coi.2012.01.01010.1016/j.coi.2012.01.010 ↗
12. 10.1016/j.lfs.2021.11915010.1016/j.lfs.2021.119150 ↗
13. 10.1073/pnas.110655010810.1073/pnas.1106550108 ↗
14. 10.1038/s42003-023-04558-y10.1038/s42003-023-04558-y ↗
15. 10.1002/anie.20140604510.1002/anie.201406045 ↗
16. 10.1523/JNEUROSCI.2381-12.201310.1523/JNEUROSCI.2381-12.2013 ↗
17. 10.1016/j.yjmcc.2012.11.00410.1016/j.yjmcc.2012.11.004 ↗
18. 10.1073/pnas.160743611310.1073/pnas.1607436113 ↗
19. 10.1091/mbc.e16-07-047810.1091/mbc.e16-07-0478 ↗
20. 10.1111/acel.1322410.1111/acel.13224 ↗
21. 10.1038/nmeth.184110.1038/nmeth.1841 ↗
22. 10.1073/pnas.131818811010.1073/pnas.1318188110 ↗
23. 10.1091/mbc.e16-06-045210.1091/mbc.e16-06-0452 ↗
24. 10.1016/j.immuni.2011.10.00410.1016/j.immuni.2011.10.004 ↗
25. 10.1039/D1NR02684D10.1039/D1NR02684D ↗
26. 10.1021/acs.analchem.8b0591910.1021/acs.analchem.8b05919 ↗
27. 10.1038/s41592-022-01463-w10.1038/s41592-022-01463-w ↗
28. 10.1364/OE.27.02102910.1364/OE.27.021029 ↗
29. 10.1038/s41592-021-01154-y10.1038/s41592-021-01154-y ↗
30. 10.1038/nmeth.389710.1038/nmeth.3897 ↗
31. 10.1038/s41467-019-10948-w10.1038/s41467-019-10948-w ↗
32. 10.1126/scitranslmed.300945710.1126/scitranslmed.3009457 ↗
33. 10.1016/j.cclet.2021.07.04810.1016/j.cclet.2021.07.048 ↗
34. 10.1016/j.cclet.2020.03.04310.1016/j.cclet.2020.03.043 ↗
35. 10.1002/cjoc.20200058310.1002/cjoc.202000583 ↗
36. 10.1073/pnas.210992311810.1073/pnas.2109923118 ↗
37. 10.1016/j.it.2004.09.01510.1016/j.it.2004.09.015 ↗
38. 10.1016/j.semcancer.2008.03.00410.1016/j.semcancer.2008.03.004 ↗
39. 10.1021/acs.jmedchem.1c0200710.1021/acs.jmedchem.1c02007 ↗
40. 10.1371/journal.pone.007761510.1371/journal.pone.0077615 ↗
41. 10.1016/j.tranon.2018.12.00110.1016/j.tranon.2018.12.001 ↗
42. 10.1038/nrneurol.2017.4610.1038/nrneurol.2017.46 ↗
43. 10.1038/nprot.2011.33610.1038/nprot.2011.336 ↗
44. 10.1021/acsnano.7b0264310.1021/acsnano.7b02643 ↗
45. 10.1016/j.immuni.2010.05.00710.1016/j.immuni.2010.05.007 ↗
46. 10.1364/OE.25.01338210.1364/OE.25.013382 ↗
47. 10.1007/s00418-014-1195-010.1007/s00418-014-1195-0 ↗
48. 10.1364/OE.22.01598210.1364/OE.22.015982 ↗